Sharla Andrews

Sharla Andrews serves as a key procurement lead within the Court Services and Offender Supervision Agency (CSOSA), overseeing acquisitions critical to the agency’s mission of public safety, rehabilitation, and reintegration of individuals under court supervision. She manages a diverse portfolio of contracts centered on behavioral health services, community-based supervision tools, and clinical support systems, ensuring alignment with evidence-based practices and federal compliance standards. Her work directly supports CSOSA’s strategic priorities by securing essential services that reduce recidivism through structured, data-driven interventions. While specific contractor names are not publicly available, Andrews maintains consistent partnerships with providers specializing in outpatient mental health counseling, substance use disorder treatment, and integrated behavioral health platforms. Her procurement approach emphasizes vendor reliability, clinical competency, and compliance with HIPAA and DOJ standards, fostering long-term relationships with firms capable of delivering scalable, trauma-informed services across the District of Columbia. Andrews demonstrates a balanced commitment to socioeconomic contracting, with approximately half of her acquisitions structured as total small business set-asides under FAR 19.5, and the other half open to all competitors. This pattern reflects a deliberate effort to expand opportunities for small businesses while maintaining flexibility to secure high-quality, specialized services. Her contracting strategy supports broad-based small business participation without favoring specific socioeconomic categories, aligning with CSOSA’s inclusive and community-focused ethos. Her primary procurement focus lies in NAICS 621330 (Offices of Mental Health Practitioners), reflecting a strong emphasis on clinical staffing, counseling services, and outpatient behavioral health programs. A secondary focus on NAICS 325414 (Biological Product Manufacturing) indicates procurement of therapeutic medications and pharmacological interventions used in substance use disorder treatment. This dual specialization underscores her technical expertise in integrating clinical care with correctional supervision systems.